SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Theragenics (TGX) on the up and up

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Boplicity who wrote (751)3/18/1998 7:05:00 AM
From: Martin Savitska  Read Replies (1) of 1055
 
Unbelievable! What's this called.....? Dain Rauscher's analyst
Parice Halbert decides to cut the rating of this stock based on
valuation. THRX has eclipsed 1998 end price target of $58. Funny
how that comes out the day after an announced stock split.
We've been flirting above $58.00 for over a month now. If Parice
is sooooo concerned about THRX's stock price, wait 2 weeks and it
will be well below 58 bucks.:>)
Guess everyone including Parice has another buying opportunity. Of
course I don't know if Parice can legally buy and sell the stock.
Looking forward to Parice having to do the same thing again before
the end of the year.:>)

Marty
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext